The bioinformatics job market appears to be recovering after a lull of several years — a trend driven largely by next-generation sequencers and other new technologies producing huge amounts of complex data.
Bioinformatics headhunter Laurie Irwin, vice-president of recruiting firm Fortune Personnel Consultants, told BioInform that while the market hasn’t recovered to where it was in its Human Genome Project “heyday,” the need remains for qualified bioinformatics staffers in both academia and industry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.